Affiliations 

  • 1 University of Manitoba, 8664, Food and human nutritional sciences, Winnipeg, Manitoba, Canada
  • 2 University of Manitoba, Human Nutritional Sciences, Winnipeg, Manitoba, Canada ; James.Friel@umanitoba.ca
  • 3 University of Manitoba, 1Department of Food and Human Nutritional Sciences, Richardson Centre for Functional Foods and Nutraceuticals. Department of Community Health Sciences, University of Manitoba, Rady Faculty of Health Sciences , Winnipeg, Manitoba, Canada ; dylan.mackay@umanitoba.ca
PMID: 31697573 DOI: 10.1139/apnm-2019-0359

Abstract

BACKGROUND: This study aims to determine the effect of pure forms of sucralose and aspartame, in doses reflective of common consumption, on glucose metabolism.

METHODS: Healthy participants consumed pure forms of a non-nutritive sweetener (NNS) mixed with water that were standardized to doses of 14% (0.425 g) of the acceptable daily intake (ADI) for aspartame and 20% (0.136 g) of the ADI for sucralose every day for two weeks. Blood samples were collected and analysed for glucose, insulin, active glucagon-like peptide-1 (GLP-1), and leptin.

RESULTS: Seventeen participants (10 females and 7 males; age 24 ± 6.8 years; BMI 22.9 ± 2.5 kg/m2) participated in the study. The total area under the curve (AUC) values of glucose, insulin, active GLP-1 and leptin were similar for the aspartame and sucralose treatment groups compared to the baseline values in healthy participants. There was no change in insulin sensitivity after NNS treatment compared to the baseline values.

CONCLUSIONS: These findings suggest that daily repeated consumption of pure sucralose or aspartame for 2 weeks had no effect on glucose metabolism among normoglycaemic adults. However, these results need to be tested in studies with longer durations. Novelty: • Daily consumption of pure aspartame or sucralose for 2 weeks had no effect on glucose metabolism. • Daily consumption of pure aspartame or sucralose for 2 weeks had no effect on insulin sensitivity among healthy adults.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.